Brief communication: The cohort of women prescribed HIV PrEP at the Veterans Health Administration.
Shimrit Keddem, Kaitlyn Broderick, Puja Van Epps, Christopher B Roberts, Sumedha Chhatre, Lauren A Beste
Author Information
Shimrit Keddem: Corporal Michael J. Crescenz Veterans Affairs (VA) Center for Health Equity, Research & Promotion (CHERP), 4100 Chester Ave, Suite 203, Philadelphia, PA, 19104, USA. shimrit.keddem@va.gov.
Kaitlyn Broderick: Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Puja Van Epps: Division of Infectious Diseases, VA Northeast Ohio Healthcare System, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, USA.
Christopher B Roberts: Corporal Michael J. Crescenz Veterans Affairs (VA) Center for Health Equity, Research & Promotion (CHERP), 4100 Chester Ave, Suite 203, Philadelphia, PA, 19104, USA.
Sumedha Chhatre: Corporal Michael J. Crescenz Veterans Affairs (VA) Center for Health Equity, Research & Promotion (CHERP), 4100 Chester Ave, Suite 203, Philadelphia, PA, 19104, USA.
Lauren A Beste: Division of General Internal Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
The goal of this study was to describe the cohort of women prescribed PrEP at the Veterans Health Administration. We used a cross-sectional study of electronic health record data. We used descriptive statistics and calculated estimated average percent change by year of prescription. A total of 417 women were prescribed PrEP over the study period. The most substantial change over time in PrEP prescribing occurred among women aged 18-24, in Other race group, and in the Western US. Though PrEP prescribing increased since its approval, more research is needed to identify barriers and expand PrEP access for women Veterans.
